Harlan S Robins Adaptive Biotechnologies Corp (ADPT) insider trading activity

Harlan S Robins is Chief Scientific Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 1.02 Million shares of ADPT, which is worth approximately $5.42 Million. The most recent transaction as insider was on Sep 13, 2021, when has been sold 3,895 shares (Common Stock) at a price of $6.32 per share, resulting in proceeds of $24,616. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.02M

0% 3M change

53.2% 12M change

Total Value Held $5.42 Million

HARLAN S ROBINS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 13 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Aug 27 2021	SELL Open market or private sale	$134,689 $34.58 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Aug 27 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Aug 26 2021	SELL Open market or private sale	$132,002 $33.89 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Aug 26 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Aug 25 2021	SELL Open market or private sale	$132,781 $34.09 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Aug 25 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Jul 21 2021	SELL Open market or private sale	$146,842 $37.7 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Jul 21 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Jul 20 2021	SELL Open market or private sale	$145,361 $37.32 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Jul 20 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Jul 19 2021	SELL Open market or private sale	$144,193 $37.02 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Jul 19 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Jun 11 2021	SELL Open market or private sale	$149,607 $38.41 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Jun 11 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Jun 10 2021	SELL Open market or private sale	$145,361 $37.32 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Jun 10 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
Jun 09 2021	SELL Open market or private sale	$141,038 $36.21 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
Jun 09 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
May 06 2021	SELL Open market or private sale	$140,025 $35.95 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
May 06 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
May 05 2021	SELL Open market or private sale	$113,199 $35.43 p/Share	3,195 Reduced 4.4%	69,360 Common Stock
May 05 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock
May 04 2021	SELL Open market or private sale	$141,778 $36.4 p/Share	3,895 Reduced 5.32%	69,360 Common Stock
May 04 2021	BUY Exercise of conversion of derivative security	$24,616 $6.32 p/Share	3,895 Added 5.05%	73,255 Common Stock

HSR

Harlan S Robins

Chief Scientific Officer

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Value

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT

Account